Yuyu Pharma, Inc. (KRX:000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,885.00
+45.00 (1.17%)
Last updated: Sep 1, 2026, 1:19 PM KST

Yuyu Pharma Revenue

Yuyu Pharma had revenue of 36.70B KRW in the quarter ending June 30, 2026, with 2.37% growth. This brings the company's revenue in the last twelve months to 144.37B, up 6.69% year-over-year. In the year 2025, Yuyu Pharma had annual revenue of 140.88B with 5.81% growth.

Revenue (ttm)
144.37B
Revenue Growth
+6.69%
P/S Ratio
0.42
Revenue / Employee
568.39M
Employees
254
Market Cap
60.47B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025140.88B7.74B5.81%
Dec 31, 2024133.15B-4.06B-2.96%
Dec 31, 2023137.21B-1.67B-1.20%
Dec 31, 2022138.88B23.23B20.08%
Dec 31, 2021115.66B17.54B17.87%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Jeil Pharma Holdings630.89B
Ildong Holdings607.65B
HANDOK560.89B
HLB Pharmaceutical251.95B
MYUNGMOON Pharm co.,Ltd199.82B
Kukje Pharma181.27B
CKD Bio159.93B
CMG Pharmaceutical115.71B
Revenue Rankings